TIAA CREF Investment Management’s Sage Therapeutics SAGE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | $61.2M | Buy |
384,925
+232,926
| +153% | +$37M | 0.04% | 357 |
|
|
2018
Q4 | $14.6M | Sell |
151,999
-17,706
| -10% | -$1.7M | 0.01% | 784 |
|
|
2018
Q3 | $24M | Sell |
169,705
-13,379
| -7% | -$1.89M | 0.02% | 665 |
|
|
2018
Q2 | $28.7M | Sell |
183,084
-47,511
| -21% | -$7.44M | 0.02% | 606 |
|
|
2018
Q1 | $37.1M | Buy |
230,595
+102,805
| +80% | +$16.6M | 0.03% | 529 |
|
|
2017
Q4 | $21M | Buy |
127,790
+7,276
| +6% | +$1.2M | 0.01% | 768 |
|
|
2017
Q3 | $7.51M | Sell |
120,514
-2,040
| -2% | -$127K | 0.01% | 1345 |
|
|
2017
Q2 | $9.76M | Buy |
122,554
+21,527
| +21% | +$1.71M | 0.01% | 1150 |
|
|
2017
Q1 | $7.18M | Sell |
101,027
-1,840
| -2% | -$131K | 0.01% | 1347 |
|
|
2016
Q4 | $5.25M | Buy |
102,867
+602
| +0.6% | +$30.7K | ﹤0.01% | 1565 |
|
|
2016
Q3 | $4.71K | Buy |
102,265
+13,744
| +16% | +$633 | ﹤0.01% | 1650 |
|
|
2016
Q2 | $2.67M | Buy |
88,521
+34,248
| +63% | +$1.03M | ﹤0.01% | 1951 |
|
|
2016
Q1 | $1.74M | Buy |
54,273
+3,227
| +6% | +$103K | ﹤0.01% | 2161 |
|
|
2015
Q4 | $2.98M | Sell |
51,046
-8,282
| -14% | -$483K | ﹤0.01% | 1908 |
|
|
2015
Q3 | $2.51M | Buy |
59,328
+14,783
| +33% | +$626K | ﹤0.01% | 2010 |
|
|
2015
Q2 | $3.25M | Buy |
44,545
+28,284
| +174% | +$2.06M | ﹤0.01% | 1983 |
|
|
2015
Q1 | $817K | Buy |
16,261
+1,865
| +13% | +$93.7K | ﹤0.01% | 2728 |
|
|
2014
Q4 | $527K | Buy |
14,396
+2,099
| +17% | +$76.8K | ﹤0.01% | 2947 |
|
|
2014
Q3 | $387K | Buy |
+12,297
| New | +$387K | ﹤0.01% | 3023 |
|